Dear Shareholders,
I am delighted to connect with you to share the Annual Report ofyour
Company, and take you through ourjourneyofCetting Closerto ourconsumers, patients,
healthcare practitioners, customers and partners through the year 2022-23.
Getting closer symbolizes your Company?s commitment to being there
for our consumers and patients when and where they need us, to bridging the gap between
cutting-edge scientific research and patient care, to extending healthcare to our
communities, and, last but not the least, to serving and caring for our own.
Over the past year, we continued to invest towards consumer awareness
programs across therapy areas towards early diagnoses, timely treatment and improved
outcomes.
To help drive visibility in our operating categories, we introduced
various continuous in-clinic education initiatives, consumer awareness campaigns, and
strategic collaborations with new-age digital platforms. Through scientifically backed
communication disseminated across new- age social and digital platforms, we worked towards
raising awareness about Iron Deficiency Anemia through the chants of Bolo India Na Na
Anemia!? powered by
Livogen; our flagship brand Neurobion empowered consumers to identify
signs of nerve damage and seek timely management to be able to Feel Life? again;
Polybion, spearheaded conversations on the role played by B vitamins in bolstering
recovery, energy, and immunity, thereby helping people to Stay Always On?; Evion,
helped educate consumers on the need to nourish from within to radiate beauty on the
outside through Evion In BeautyOn?; and, and Nasivion reiterated the promise to
provide Fast Relief for nasal congestion. The year alsowitnessed us set a new benchmark in
association with the Indian Medical Association, byachieving a GUINNESS WORLD RECORD™
for the Largest Attendance for a Virtual Pharmaceutical Conference in one day? during
our first-ever Phygital? Recovery Summit 2023.
Our collaboration with healthcare professionals, pharmacists, and
healthcare organizations, helped foster betterscientific collaboration and
knowledge-sharing within the medical fraternity, thereby facilitating to build an
ecosystem empowering HCPs and pharmacists to deliver the best possible care to patients.
We did this through bespoke scientific exchange forums such as Blood Health Forum, Nerve
Care Forum, the Care Summit, Recovery Summit, thereby engaging experts within the
industry. These engagements helped drive ourcore beliefof bringing care closer to patients
through innovative approaches.
We bolstered ourgo-to-market strategy and strengthened our partnerships
across omni channel stores, increasing the availability and access ofour brands across
online and offline platforms, thereby helping meet the needs of our consumers and
customers.
Together, these efforts have helped us deliver resilient performance
and consistent growth through the year amidst significant industry headwinds, a tough
competitive landscape and category slowdown.
Your Company?s continues to be guided by our strong citizenship
framework based on key pillars ofCommunity Impact, Equality and Inclusion and
Environmental Sustainability, with a strong foundation of Ethics and Corporate Social
Responsibility (CSR) guiding everything we do. SEHAT, our flagship CSR program, continued
to remain a priorityduring this fiscal yearwhere we continued to strengthen public health
through our strategic initiatives. Our Employees also made a strong contribution to SEHAT
through volunteering initiatives with our partner NGOs, and our Annual Joy of Giving
Internal Campaign.
Moving ahead, we remain focused on our integrated strategywhich
comprises a portfolioofquality, trusted and highly recommended healthcare productswhere
performance drives brand choice; with superiority across product, package, brand
communication, retail execution, and value; productivity; constructive disruption; and an
agile, empowered organization. We believe these are the right strategies to help us
navigate our short and mid-term challenges and help us deliver balanced growth.
I would like to take this opportunity to thank each ofyou, our dear
shareholders, for your steadfast support.
Step by step, quarter on quarter, initiative by initiative we continue
determined to become a leading Company in Consumer Health in India. With a strategic
interest in the health and well-being ofconsumers, strong portfolio of brands backed by
science and trusted by doctors, consumers and pharmacists, the passion and perseverance
ofour talented and passionate team, and yoursupport and encouragement, we believe we can
make it happen.